GAD-65 Activators

Common GAD-65 Activators include, but are not limited to Valproic Acid CAS 99-66-1, Gabapentin CAS 60142-96-3, (±)-Baclofen CAS 1134-47-0, Kainic acid monohydrate CAS 58002-62-3 and Forskolin CAS 66575-29-9.

GAD-65, Glutamate Decarboxylase 65, is one of the two primary isoforms of the enzyme responsible for converting the excitatory neurotransmitter glutamate into the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) within neurons. The numeric identifier "65" in its name refers to its molecular weight, which is approximately 65 kDa. GAD-65, along with its counterpart GAD-67, plays a pivotal role in ensuring a balanced ratio of excitatory to inhibitory signals within the central nervous system. While both isoforms serve the same fundamental enzymatic role, they are differentially expressed throughout the brain and have distinct intracellular distributions. GAD-65 is primarily associated with nerve terminals and is believed to be involved in synthesizing GABA for neurotransmission, whereas GAD-67 seems more uniformly distributed within neurons and is thought to be responsible for synthesizing GABA for neuron's metabolic needs.

GAD-65 Activators, by their inherent nature, are compounds intended to bolster or potentiate the enzymatic activity of the GAD-65 protein. Such compounds could significantly influence the synthesis rates of GABA from glutamate, thereby having a profound effect on neurotransmission balance within the central nervous system. Enhancing GAD-65 activity could lead to an increased conversion of glutamate to GABA, tipping the balance towards inhibitory neurotransmission. The chemical design of such activators would require a keen understanding of the enzyme's structure and function, as well as its interactions within the cellular environment. Engaging with GAD-65's activity through these activators offers a profound window into the delicate interplay of excitatory and inhibitory processes that orchestrate the myriad of functions within the brain.